We have analyzed the expression of PDGFRα, A2B5, O4 and CD44 as surface markers for glial precursor cells [17], [20]–[24], [27]–[30], and CD133 for stem cells [7], [17] on freshly prepared glioma cells using flow cytometry. This evidence concerns the gene CD44 and central nervous system cancer.